37 related articles for article (PubMed ID: 34582789)
1. Dendrimer nanotherapy targeting of glial dysfunction improves inflammation and neurobehavioral phenotype in adult female Mecp2-heterozygous mouse model of Rett syndrome.
Khoury ES; Patel RV; O'Ferrall C; Fowler A; Sah N; Sharma A; Gupta S; Scafidi S; Kurtz JS; Olmstead SJ; Kudchadkar SR; Kannan RM; Blue ME; Kannan S
J Neurochem; 2024 May; 168(5):841-854. PubMed ID: 37777475
[TBL] [Abstract][Full Text] [Related]
2. Modulation of RhoGTPases improves the behavioral phenotype and reverses astrocytic deficits in a mouse model of Rett syndrome.
De Filippis B; Fabbri A; Simone D; Canese R; Ricceri L; Malchiodi-Albedi F; Laviola G; Fiorentini C
Neuropsychopharmacology; 2012 Apr; 37(5):1152-63. PubMed ID: 22157810
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for Rett syndrome.
De Filippis B; Nativio P; Fabbri A; Ricceri L; Adriani W; Lacivita E; Leopoldo M; Passarelli F; Fuso A; Laviola G
Neuropsychopharmacology; 2014 Oct; 39(11):2506-18. PubMed ID: 24809912
[TBL] [Abstract][Full Text] [Related]
4. Deficits in skilled motor and auditory learning in a rat model of Rett syndrome.
Adcock KS; Blount AE; Morrison RA; Alvarez-Dieppa A; Kilgard MP; Engineer CT; Hays SA
J Neurodev Disord; 2020 Sep; 12(1):27. PubMed ID: 32988374
[TBL] [Abstract][Full Text] [Related]
5. Reversal of neurological deficits by painless nerve growth factor in a mouse model of Rett syndrome.
Tiberi A; Borgonovo G; Testa G; Pacifico P; Jacob A; Di Caprio M; Totaro V; Calvello M; Cattaneo A; Capsoni S
Brain; 2024 Jan; 147(1):122-134. PubMed ID: 37633263
[TBL] [Abstract][Full Text] [Related]
6. Antisense oligonucleotide therapy in a humanized mouse model of
Shao Y; Sztainberg Y; Wang Q; Bajikar SS; Trostle AJ; Wan YW; Jafar-Nejad P; Rigo F; Liu Z; Tang J; Zoghbi HY
Sci Transl Med; 2021 Mar; 13(583):. PubMed ID: 33658357
[TBL] [Abstract][Full Text] [Related]
7.
Albizzati E; Breccia M; Florio E; Cabasino C; Postogna FM; Grassi R; Boda E; Battaglia C; De Palma C; De Quattro C; Pozzi D; Landsberger N; Frasca A
iScience; 2024 Mar; 27(3):109296. PubMed ID: 38469559
[TBL] [Abstract][Full Text] [Related]
8. Improved
Sinnett SE; Hector RD; Gadalla KKE; Heindel C; Chen D; Zaric V; Bailey MES; Cobb SR; Gray SJ
Mol Ther Methods Clin Dev; 2017 Jun; 5():106-115. PubMed ID: 28497072
[TBL] [Abstract][Full Text] [Related]
9. Free as a BRD4: Bromodomain Inhibition Ameliorates Disease Phenotypes in a Model of
Lamar KJ; Carvill GL
Epilepsy Curr; 2020; 20(6):390-392. PubMed ID: 34025262
[No Abstract] [Full Text] [Related]
10. Look at DAYBUE™ (Trofinetide) as first ever drug for treatment of Rett Syndrome.
Tareen MK; Mohiyuddin Z
Asian J Psychiatr; 2024 May; 95():104011. PubMed ID: 38555801
[No Abstract] [Full Text] [Related]
11. Trofinetide: a pioneering treatment for Rett syndrome.
Parent H; Ferranti A; Niswender C
Trends Pharmacol Sci; 2023 Oct; 44(10):740-741. PubMed ID: 37460385
[TBL] [Abstract][Full Text] [Related]
12. Increasing histone acetylation improves sociability and restores learning and memory in KAT6B-haploinsufficient mice.
Bergamasco MI; Vanyai HK; Garnham AL; Geoghegan ND; Vogel AP; Eccles S; Rogers KL; Smyth GK; Blewitt ME; Hannan AJ; Thomas T; Voss AK
J Clin Invest; 2024 Apr; 134(7):. PubMed ID: 38557491
[TBL] [Abstract][Full Text] [Related]
13. The role of altered protein acetylation in neurodegenerative disease.
Kabir F; Atkinson R; Cook AL; Phipps AJ; King AE
Front Aging Neurosci; 2022; 14():1025473. PubMed ID: 36688174
[TBL] [Abstract][Full Text] [Related]
14. Tubulin Cytoskeleton in Neurodegenerative Diseases-not Only Primary Tubulinopathies.
Cyske Z; Gaffke L; Pierzynowska K; Węgrzyn G
Cell Mol Neurobiol; 2023 Jul; 43(5):1867-1884. PubMed ID: 36352320
[TBL] [Abstract][Full Text] [Related]
15. Multimodal Neuroimaging in Rett Syndrome With
Kong Y; Li QB; Yuan ZH; Jiang XF; Zhang GQ; Cheng N; Dang N
Front Neurol; 2022; 13():838206. PubMed ID: 35280272
[TBL] [Abstract][Full Text] [Related]
16. Excitation and Inhibition Imbalance in Rett Syndrome.
Li W
Front Neurosci; 2022; 16():825063. PubMed ID: 35250460
[TBL] [Abstract][Full Text] [Related]
17. Identification of Region-Specific Cytoskeletal and Molecular Alterations in Astrocytes of
Albizzati E; Florio E; Miramondi F; Sormonta I; Landsberger N; Frasca A
Front Neurosci; 2022; 16():823060. PubMed ID: 35242007
[TBL] [Abstract][Full Text] [Related]
18. HDAC inhibitor ameliorates behavioral deficits in Mecp2
Lebrun N; Delépine C; Selloum M; Meziane H; Nectoux J; Herault Y; Bienvenu T
Brain Res; 2021 Dec; 1772():147670. PubMed ID: 34582789
[TBL] [Abstract][Full Text] [Related]
19. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors.
Gold WA; Lacina TA; Cantrill LC; Christodoulou J
J Mol Med (Berl); 2015 Jan; 93(1):63-72. PubMed ID: 25209898
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
